TreeWAS – Variant ID: rs6691768

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
M18.9 Arthrosis of first carpometacarpal joint, unspecified	0.034	0.966	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.012	0.988	0.000
T40.2 Other opioids	0.012	0.988	0.000
T40.4 Other synthetic narcotics	0.011	0.989	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.011	0.989	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.011	0.989	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.010	0.990	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.010	0.990	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.010	0.990	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.009	0.991	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.009	0.991	0.000
T40.1 Heroin	0.009	0.991	0.000
T40.6 Other and unspecified narcotics	0.009	0.991	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.009	0.991	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.009	0.991	0.000
T36 Poisoning by systemic antibiotics	0.009	0.991	0.000
H04.1 Other disorders of lachrymal gland	0.009	0.991	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.009	0.991	0.000
T40.8 Lysergide [LSD]	0.009	0.991	0.000
T40.7 Cannabis (derivatives)	0.009	0.991	0.000
T40.0 Opium	0.009	0.991	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.009	0.991	0.000
T40.3 Methadone	0.009	0.991	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.009	0.991	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.008	0.991	0.000
T40.5 Cocaine	0.008	0.992	0.000
T50.8 Diagnostic agents	0.008	0.992	0.000
T42.1 Iminostilbenes	0.008	0.992	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.008	0.992	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.008	0.992	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.008	0.992	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.008	0.992	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.008	0.992	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.008	0.992	0.000
T50.1 Loop [high-ceiling] diuretics	0.008	0.992	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.007	0.992	0.000
T42.3 Barbiturates	0.007	0.992	0.000
T42.2 Succinimides and oxazolidinediones	0.007	0.992	0.000
T42.0 Hydantoin derivatives	0.007	0.992	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.008	0.992	0.000
T43.6 Psychostimulants with abuse potential	0.008	0.992	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.007	0.993	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.007	0.993	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.007	0.993	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.007	0.993	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.007	0.993	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.007	0.993	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.007	0.993	0.000
T44.0 Anticholinesterase agents	0.007	0.993	0.000
T36.0 Penicillins	0.007	0.993	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.007	0.993	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.007	0.993	0.000
T37.5 Antiviral drugs	0.007	0.993	0.000
T37.4 Anthelminthics	0.007	0.993	0.000
T37.3 Other antiprotozoal drugs	0.007	0.993	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.007	0.993	0.000
T37.1 Antimycobacterial drugs	0.007	0.993	0.000
T37.0 Sulphonamides	0.007	0.993	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.007	0.993	0.000
T36.8 Other systemic antibiotics	0.007	0.993	0.000
T38.1 Thyroid hormones and substitutes	0.007	0.993	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.007	0.993	0.000
U80 Agent resistant to penicillin and related antibiotics	0.000	0.993	0.007
T38.0 Glucocorticoids and synthetic analogues	0.007	0.993	0.000
M72.04 Palmar fascial fibromatosis [Dupuytren]-Hand	0.007	0.993	0.000
U80.0 Penicillin resistant agent	0.000	0.993	0.007
U80.1 Methicillin resistant agent	0.000	0.993	0.007
T50.7 Analeptics and opioid receptor antagonists	0.007	0.993	0.000
T50.5 Appetite depressants	0.007	0.993	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.007	0.993	0.000
T50.0 Mineralocorticoids and their antagonists	0.007	0.993	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.007	0.993	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.007	0.993	0.000
T38.9 Other and unspecified hormone antagonists	0.007	0.993	0.000
T38.7 Androgens and anabolic congeners	0.007	0.993	0.000
T38.5 Other oestrogens and progestogens	0.007	0.993	0.000
T38.4 Oral contraceptives	0.007	0.993	0.000
T38.2 Antithyroid drugs	0.007	0.993	0.000
T47.0 Histamine H(2)-receptor antagonists	0.007	0.993	0.000
T36.3 Macrolides	0.007	0.993	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.007	0.993	0.000
T36.9 Systemic antibiotic, unspecified	0.007	0.993	0.000
T36.7 Antifungal antibiotics, systemically used	0.007	0.993	0.000
T36.6 Rifamycins	0.007	0.993	0.000
T36.5 Aminoglycosides	0.007	0.993	0.000
T36.2 Chloramphenicol group	0.007	0.993	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.007	0.993	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.007	0.993	0.000
T47.4 Other laxatives	0.007	0.993	0.000
T36.4 Tetracyclines	0.006	0.993	0.000
T50.4 Drugs affecting uric acid metabolism	0.006	0.994	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.006	0.994	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.006	0.994	0.000
T47.7 Emetics	0.006	0.994	0.000
T47.5 Digestants	0.006	0.994	0.000
T47.3 Saline and osmotic laxatives	0.006	0.994	0.000
T43.9 Psychotropic drug, unspecified	0.006	0.994	0.000
U88 Agent resistant to multiple antibiotics	0.000	0.994	0.006
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.006	0.994	0.000
T47.2 Stimulant laxatives	0.006	0.994	0.000
T42.4 Benzodiazepines	0.006	0.994	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.006	0.994	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.006	0.994	0.000
T41.5 Therapeutic gases	0.006	0.994	0.000
T41.4 Anaesthetic, unspecified	0.006	0.994	0.000
T41.3 Local anaesthetics	0.006	0.994	0.000
T41.2 Other and unspecified general anaesthetics	0.006	0.994	0.000
T41.1 Intravenous anaesthetics	0.006	0.994	0.000
T41.0 Inhaled anaesthetics	0.006	0.994	0.000
T47.6 Antidiarrhoeal drugs	0.006	0.994	0.000
T49.9 Topical agent, unspecified	0.006	0.994	0.000
T49.8 Other topical agents	0.006	0.994	0.000
T49.7 Dental drugs, topically applied	0.006	0.994	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.006	0.994	0.000
T49.5 Ophthalmological drugs and preparations	0.006	0.994	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.006	0.994	0.000
T49.3 Emollients, demulcents and protectants	0.006	0.994	0.000
T49.2 Local astringents and local detergents	0.006	0.994	0.000
T49.1 Antipruritics	0.006	0.994	0.000
U80.8 Agent resistant to other penicillin-related antibiotic	0.000	0.994	0.006
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.006	0.994	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.006	0.994	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.005	0.994	0.000
H47.3 Other disorders of optic disk	0.005	0.994	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.005	0.994	0.000
T48.4 Expectorants	0.005	0.994	0.000
T48.3 Antitussives	0.005	0.994	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.005	0.994	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.005	0.994	0.000
T48.0 Oxytocic drugs	0.005	0.994	0.000
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.000	0.995	0.005
M72.0 Palmar fascial fibromatosis [Dupuytren]	0.005	0.995	0.000
T48.5 Anti-common-cold drugs	0.005	0.995	0.000
R01.1 Cardiac murmur, unspecified	0.005	0.995	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.005	0.995	0.000
U82-U85 Resistance to antimicrobial and antineoplastic drugs	0.000	0.995	0.005
T46.8 Antivaricose drugs, including sclerosing agents	0.005	0.995	0.000
T46.7 Peripheral vasodilators	0.005	0.995	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.005	0.995	0.000
T43.2 Other and unspecified antidepressants	0.005	0.995	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.005	0.995	0.000
T46.1 Calcium-channel blockers	0.005	0.995	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.005	0.995	0.000
M72.09 Palmar fascial fibromatosis [Dupuytren]-Site unspec	0.005	0.995	0.000
N19 Unspecified renal failure	0.000	0.995	0.005
D22.5 Melanocytic naevi of trunk	0.000	0.995	0.005
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.004	0.995	0.000
I74.5 Embolism and thrombosis of iliac artery	0.005	0.995	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.004	0.995	0.000
M18 Arthrosis of first carpometacarpal joint	0.005	0.995	0.000
Chapter XXII Codes for special purposes	0.000	0.995	0.004
U81 Agent resistant to vancomycin and related antibiotics	0.000	0.996	0.004
T46.3 Coronary vasodilators, not elsewhere classified	0.004	0.996	0.000
M72.00 Palmar fascial fibromatosis [Dupuytren]-Mult sites	0.004	0.996	0.000
H47 Other disorders of optic [2nd] nerve and visual pathways	0.004	0.996	0.000
T45.2 Vitamins, not elsewhere classified	0.004	0.996	0.000
U50 Level of care administered to neonates	0.000	0.996	0.004
U07 Emergency use of U07	0.000	0.996	0.004
U06 Emergency use of U06	0.000	0.996	0.004
U04 Severe acute respiratory syndrome [SARS]	0.000	0.996	0.004
U52 First in a series of a regular day/night admissions	0.000	0.996	0.004
M72.08 Palmar fascial fibromatosis [Dupuytren]-Other	0.004	0.996	0.000
M72.06 Palmar fascial fibromatosis [Dupuytren]-Lower Leg	0.004	0.996	0.000
M72.05 Palmar fascial fibromatosis [Dupuytren]-Pelvic/Thigh	0.004	0.996	0.000
M72.03 Palmar fascial fibromatosis [Dupuytren]-Forearm	0.004	0.996	0.000
M72.02 Palmar fascial fibromatosis [Dupuytren]-Upper arm	0.004	0.996	0.000
M72.01 Palmar fascial fibromatosis [Dupuytren]-Shldr region	0.004	0.996	0.000
M72.07 Palmar fascial fibromatosis [Dupuytren]-Ankle/Foot	0.004	0.996	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.004	0.996	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.004	0.996	0.000
T45.8 Other primarily systemic and haematological agents	0.004	0.996	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.004	0.996	0.000
T45.6 Fibrinolysis-affecting drugs	0.004	0.996	0.000
T45.4 Iron and its compounds	0.004	0.996	0.000
T45.3 Enzymes, not elsewhere classified	0.004	0.996	0.000
U84 Resistance to other antimicrobial drugs	0.000	0.996	0.004
U83 Resistance to other antibiotics	0.000	0.996	0.004
U82 Resistance to betalactam antibiotics	0.000	0.996	0.004
U85 Resistance to antineoplastic drugs	0.000	0.996	0.004
T50.9 Other and unspecified drugs, medicaments and biological substances	0.004	0.996	0.000
H47.1 Papilloedema, unspecified	0.004	0.996	0.000
U89 Agent resistant to other and unspecified antibiotics	0.000	0.996	0.004
G04.9 Encephalitis, myelitis and encephalomyelitis, unspecified	0.004	0.996	0.000
H47.2 Optic atrophy	0.004	0.996	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.004	0.996	0.000
T45.0 Antiallergic and antiemetic drugs	0.004	0.996	0.000
N61 Inflammatory disorders of breast	0.004	0.996	0.000
H47.5 Disorders of other visual pathways	0.004	0.996	0.000
U81.0 Vancomycin resistant agent	0.000	0.996	0.003
U81.8 Agent resistant to other vancomycin-related antibiotic	0.000	0.996	0.003
M18.5 Other secondary arthrosis of first carpometacarpal joint	0.003	0.996	0.000
M18.4 Other secondary arthrosis of first carpometacarpal joints, bilateral	0.003	0.996	0.000
M18.2 Posttraumatic arthrosis of first carpometacarpal joints, bilateral	0.003	0.996	0.000
T17.2 Foreign body in pharynx	0.004	0.996	0.000
G40.5 Special epileptic syndromes	0.003	0.996	0.000
U51 Admission status on psychiatric patients	0.000	0.996	0.003
G40.2 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures	0.003	0.997	0.000
Z31.0 Tuboplasty or vasoplasty after previous sterilisation	0.003	0.997	0.000
D26.1 Corpus uteri	0.000	0.997	0.003
G40.6 Grand mal seizures, unspecified (with or without petit mal)	0.003	0.997	0.000
M84.03 Malunion of fracture (Forearm)	0.003	0.997	0.000
H47.7 Disorder of visual pathways, unspecified	0.003	0.997	0.000
H47.6 Disorders of visual cortex	0.003	0.997	0.000
H47.4 Disorders of optic chiasm	0.003	0.997	0.000
M18.3 Other posttraumatic arthrosis of first carpometacarpal joint	0.003	0.997	0.000
K90.0 Coeliac disease	0.003	0.997	0.000
U04.9 Severe acute respiratory syndrome [SARS], unspecified	0.000	0.997	0.003
U06.9 Emergency use of U06.9	0.000	0.997	0.003
U06.8 Emergency use of U06.8	0.000	0.997	0.003
U06.7 Emergency use of U06.7	0.000	0.997	0.003
U06.6 Emergency use of U06.6	0.000	0.997	0.003
U06.5 Emergency use of U06.5	0.000	0.997	0.003
U06.4 Emergency use of U06.4	0.000	0.997	0.003
U06.3 Emergency use of U06.3	0.000	0.997	0.003
U06.2 Emergency use of U06.2	0.000	0.997	0.003
U06.1 Emergency use of U06.1	0.000	0.997	0.003
U06.0 Emergency use of U06.0	0.000	0.997	0.003
U07.9 Emergency use of U07.9	0.000	0.997	0.003
U07.8 Emergency use of U07.8	0.000	0.997	0.003
U07.7 Emergency use of U07.7	0.000	0.997	0.003
U07.6 Emergency use of U07.6	0.000	0.997	0.003
U07.5 Emergency use of U07.5	0.000	0.997	0.003
U07.4 Emergency use of U07.4	0.000	0.997	0.003
U07.3 Emergency use of U07.3	0.000	0.997	0.003
U07.2 Emergency use of U07.2	0.000	0.997	0.003
U07.1 Emergency use of U07.1	0.000	0.997	0.003
U07.0 Emergency use of U07.0	0.000	0.997	0.003
U50.9 Inquest Adjourned Death	0.000	0.997	0.003
U50.3 Level of care administered to neonates (Maximal Intensive Care)	0.000	0.997	0.003
U50.2 Level of care administered to neonates (High Dependancy Intensive Care)	0.000	0.997	0.003
U50.1 Level of care administered to neonates (Special Care)	0.000	0.997	0.003
U50.0 Level of care administered to neonates (Normal Care)	0.000	0.997	0.003
C50.2 Upper-inner quadrant of breast	0.003	0.997	0.000
U89.9 Agent resistant to unspecified antibiotic	0.000	0.997	0.003
U82.9 Resistance to betalactam antibiotics, unspecified	0.000	0.997	0.003
U82.8 Resistance to other betalactam antibiotics	0.000	0.997	0.003
U82.2 Extended spectrum betalactamase (ESBL) resistance	0.000	0.997	0.003
U82.1 Resistance to methicillin	0.000	0.997	0.003
U82.0 Resistance to penicillin	0.000	0.997	0.003
U83.9 Resistance to unspecified antibiotic	0.000	0.997	0.003
U83.8 Resistance to other single specified antibiotic	0.000	0.997	0.003
U83.7 Resistance to multiple antibiotics	0.000	0.997	0.003
U83.2 Resistance to quinolones	0.000	0.997	0.003
U83.1 Resistance to other vancomycin related antibiotics	0.000	0.997	0.003
U83.0 Resistance to vancomycin	0.000	0.997	0.003
U84.9 Resistance to unspecified antimicrobial drugs	0.000	0.997	0.003
U84.8 Resistance to other specified antimicrobial drug	0.000	0.997	0.003
U84.7 Resistance to multiple antimicrobial drugs	0.000	0.997	0.003
U84.3 Resistance to tuberculostatic drug(s)	0.000	0.997	0.003
U84.2 Resistance to antiviral drug(s)	0.000	0.997	0.003
U84.1 Resistance to antifungal drug(s)	0.000	0.997	0.003
U84.0 Resistance to antiparasitic drug(s)	0.000	0.997	0.003
H55 Nystagmus and other irregular eye movements	0.003	0.997	0.000
M84.06 Malunion of fracture (Lower leg)	0.003	0.997	0.000
N13.9 Obstructive and reflux uropathy, unspecified	0.000	0.997	0.003
G40 Epilepsy	0.003	0.997	0.000
T45.5 Anticoagulants	0.003	0.997	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.003	0.997	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.003	0.997	0.000
M84.0 Malunion of fracture	0.003	0.997	0.000
M72 Fibroblastic disorders	0.003	0.997	0.000
T39.4 Antirheumatics, not elsewhere classified	0.003	0.997	0.000
T39.2 Pyrazolone derivatives	0.003	0.997	0.000
X63.0 Home	0.003	0.997	0.000
G04 Encephalitis, myelitis and encephalomyelitis	0.003	0.997	0.000
M84.04 Malunion of fracture (Hand)	0.003	0.997	0.000
H47.0 Disorders of optic nerve, not elsewhere classified	0.003	0.997	0.000
T39.0 Salicylates	0.003	0.997	0.000
I74.9 Embolism and thrombosis of unspecified artery	0.003	0.997	0.000
N13.4 Hydroureter	0.000	0.997	0.003
N13.6 Pyonephrosis	0.000	0.997	0.003
M18.0 Primary arthrosis of first carpometacarpal joints, bilateral	0.003	0.997	0.000
M84.05 Malunion of fracture (Pelvic region and thigh)	0.003	0.997	0.000
G40.4 Other generalised epilepsy and epileptic syndromes	0.003	0.997	0.000
U51.2 Previously admitted to a psychiatric hospital of another provider	0.000	0.997	0.003
U51.1 Previously admitted to a psychiatric hospital of the provider	0.000	0.997	0.003
G30.9 Alzheimer's disease, unspecified	0.003	0.997	0.000
G40.0 Localisation-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localised onset	0.003	0.997	0.000
M72.5 Fasciitis, not elsewhere classified	0.003	0.997	0.000
M84.01 Malunion of fracture (Shoulder region)	0.003	0.997	0.000
N13 Obstructive and reflux uropathy	0.000	0.997	0.003
G04.0 Acute disseminated encephalitis	0.003	0.997	0.000
M72.6 Necrotizing fasciitis	0.003	0.997	0.000
U89.8 Agent resistant to other single specified antibiotic	0.000	0.997	0.003
N13.0 Hydronephrosis with ureteropelvic junction obstruction	0.000	0.997	0.003
G04.2 Bacterial meningoencephalitis and meningomyelitis, not elsewhere classified	0.002	0.997	0.000
N42.1 Congestion and haemorrhage of prostate	0.000	0.997	0.003
I74 Arterial embolism and thrombosis	0.003	0.997	0.000
G04.8 Other encephalitis, myelitis and encephalomyelitis	0.002	0.997	0.000
G40.7 Petit mal, unspecified, without grand mal seizures	0.002	0.997	0.000
M72.9 Fibroblastic disorder, unspecified	0.002	0.997	0.000
N13.1 Hydronephrosis with ureteral stricture, not elsewhere classified	0.000	0.997	0.003
J86.9 Pyothorax without fistula	0.000	0.997	0.002
G40.8 Other epilepsy	0.002	0.998	0.000
M84.08 Malunion of fracture (Other)	0.002	0.998	0.000
R63.0 Anorexia	0.000	0.998	0.002
M84.09 Malunion of fracture (Site unspecified)	0.002	0.998	0.000
M84.00 Malunion of fracture (Multiple sites)	0.002	0.998	0.000
M72.8 Other fibroblastic disorders	0.002	0.998	0.000
M72.4 Pseudosarcomatous fibromatosis	0.002	0.998	0.000
M72.3 Nodular fasciitis	0.002	0.998	0.000
M72.68 Necrotizing fasciitis (Other)	0.002	0.998	0.000
M72.1 Knuckle pads	0.002	0.998	0.000
M72.58 Fasciitis, not elsewhere classified-Other	0.002	0.998	0.000
G04.1 Tropical spastic paraplegia	0.002	0.998	0.000
M84.02 Malunion of fracture (Upper arm)	0.002	0.998	0.000
G40.3 Generalised idiopathic epilepsy and epileptic syndromes	0.002	0.998	0.000
H54.4 Blindness, one eye	0.002	0.998	0.000
I11.9 Hypertensive heart disease without (congestive) heart failure	0.000	0.998	0.002
N13.7 Vesicoureteral-reflux-associated uropathy	0.000	0.998	0.002
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.002	0.998	0.000
M72.55 Fasciitis, not elsewhere classified-Pelvic/Thigh	0.002	0.998	0.000
I20.1 Angina pectoris with documented spasm	0.002	0.998	0.000
I11.0 Hypertensive heart disease with (congestive) heart failure	0.000	0.998	0.002
I74.3 Embolism and thrombosis of arteries of the lower extremities	0.002	0.998	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.002	0.998	0.000
I74.1 Embolism and thrombosis of other and unspecified parts of aorta	0.002	0.998	0.000
Z97.4 Presence of external hearing-aid	0.002	0.998	0.000
X63 Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous system	0.002	0.998	0.000
M72.59 Fasciitis, not elsewhere classified-Site unspec	0.002	0.998	0.000
M72.57 Fasciitis, not elsewhere classified-Ankle/Foot	0.002	0.998	0.000
M72.56 Fasciitis, not elsewhere classified-Lower Leg	0.002	0.998	0.000
M72.54 Fasciitis, not elsewhere classified-Hand	0.002	0.998	0.000
M72.53 Fasciitis, not elsewhere classified-Forearm	0.002	0.998	0.000
M72.52 Fasciitis, not elsewhere classified-Upper arm	0.002	0.998	0.000
M72.51 Fasciitis, not elsewhere classified-Shldr region	0.002	0.998	0.000
M72.50 Fasciitis, not elsewhere classified-Mult sites	0.002	0.998	0.000
M72.69 Necrotizing fasciitis (Site unspecified)	0.002	0.998	0.000
M72.67 Necrotizing fasciitis (Ankle and foot)	0.002	0.998	0.000
M72.66 Necrotizing fasciitis (Lower leg)	0.002	0.998	0.000
M72.65 Necrotizing fasciitis (Pelvic region and thigh)	0.002	0.998	0.000
M72.64 Necrotizing fasciitis (Hand)	0.002	0.998	0.000
M72.63 Necrotizing fasciitis (Forearm)	0.002	0.998	0.000
M72.62 Necrotizing fasciitis (Upper arm)	0.002	0.998	0.000
M72.61 Necrotizing fasciitis (Shoulder region)	0.002	0.998	0.000
M72.60 Necrotizing fasciitis (Multiple sites)	0.002	0.998	0.000
U51.0 Not Previously admitted to a psyciatric hospital	0.000	0.998	0.002
M72.94 Fibroblastic disorder, unspecified (Hand)	0.002	0.998	0.000
N13.5 Kinking and stricture of ureter without hydronephrosis	0.000	0.998	0.002
S52.10 Fracture of upper end of radius (closed)	0.002	0.998	0.000
M72.2 Plantar fascial fibromatosis	0.002	0.998	0.000
M72.99 Fibroblastic disorder, unspecified (Site unspecified)	0.002	0.998	0.000
M72.98 Fibroblastic disorder, unspecified (Other)	0.002	0.998	0.000
M72.97 Fibroblastic disorder, unspecified (Ankle and foot)	0.002	0.998	0.000
M72.96 Fibroblastic disorder, unspecified (Lower leg)	0.002	0.998	0.000
M72.95 Fibroblastic disorder, unspecified (Pelvic region and thigh)	0.002	0.998	0.000
M72.93 Fibroblastic disorder, unspecified (Forearm)	0.002	0.998	0.000
M72.92 Fibroblastic disorder, unspecified (Upper arm)	0.002	0.998	0.000
M72.91 Fibroblastic disorder, unspecified (Shoulder region)	0.002	0.998	0.000
M72.90 Fibroblastic disorder, unspecified (Multiple sites)	0.002	0.998	0.000
R23.2 Flushing	0.000	0.998	0.002
Z94.4 Liver transplant status	0.000	0.998	0.002
K90.9 Intestinal malabsorption, unspecified	0.002	0.998	0.000
K90.8 Other intestinal malabsorption	0.002	0.998	0.000
I74.4 Embolism and thrombosis of arteries of extremities, unspecified	0.002	0.998	0.000
M19.99 Arthrosis, unspecified (Site unspecified)	0.000	0.998	0.002
M72.39 Nodular fasciitis-Site unspec	0.002	0.998	0.000
M72.38 Nodular fasciitis-Other	0.002	0.998	0.000
M72.37 Nodular fasciitis-Ankle/Foot	0.002	0.998	0.000
M72.36 Nodular fasciitis-Lower Leg	0.002	0.998	0.000
M72.35 Nodular fasciitis-Pelvic/Thigh	0.002	0.998	0.000
M72.34 Nodular fasciitis-Hand	0.002	0.998	0.000
M72.33 Nodular fasciitis-Forearm	0.002	0.998	0.000
M72.32 Nodular fasciitis-Upper arm	0.002	0.998	0.000
M72.31 Nodular fasciitis-Shldr region	0.002	0.998	0.000
M72.30 Nodular fasciitis-Mult sites	0.002	0.998	0.000
M72.49 Pseudosarcomatous fibromatosis (Site unspecified)	0.002	0.998	0.000
M72.48 Pseudosarcomatous fibromatosis (Other)	0.002	0.998	0.000
M72.47 Pseudosarcomatous fibromatosis (Ankle and foot)	0.002	0.998	0.000
M72.46 Pseudosarcomatous fibromatosis (Lower leg)	0.002	0.998	0.000
M72.45 Pseudosarcomatous fibromatosis (Pelvic region and thigh)	0.002	0.998	0.000
M72.44 Pseudosarcomatous fibromatosis (Hand)	0.002	0.998	0.000
M72.43 Pseudosarcomatous fibromatosis (Forearm)	0.002	0.998	0.000
M72.42 Pseudosarcomatous fibromatosis (Upper arm)	0.002	0.998	0.000
M72.41 Pseudosarcomatous fibromatosis (Shoulder region)	0.002	0.998	0.000
M72.40 Pseudosarcomatous fibromatosis (Multiple sites)	0.002	0.998	0.000
M72.89 Other fibroblastic disorders (Site unspecified)	0.002	0.998	0.000
M72.88 Other fibroblastic disorders (Other)	0.002	0.998	0.000
M72.87 Other fibroblastic disorders (Ankle and foot)	0.002	0.998	0.000
M72.86 Other fibroblastic disorders (Lower leg)	0.002	0.998	0.000
M72.85 Other fibroblastic disorders (Pelvic region and thigh)	0.002	0.998	0.000
M72.84 Other fibroblastic disorders (Hand)	0.002	0.998	0.000
M72.83 Other fibroblastic disorders (Forearm)	0.002	0.998	0.000
M72.82 Other fibroblastic disorders (Upper arm)	0.002	0.998	0.000
M72.81 Other fibroblastic disorders (Shoulder region)	0.002	0.998	0.000
M72.80 Other fibroblastic disorders (Multiple sites)	0.002	0.998	0.000
K90 Intestinal malabsorption	0.002	0.998	0.000
M72.19 Knuckle pads (Site unspecified)	0.002	0.998	0.000
M72.18 Knuckle pads-Other	0.002	0.998	0.000
M72.17 Knuckle pads (Ankle and foot)	0.002	0.998	0.000
M72.16 Knuckle pads-Lower Leg	0.002	0.998	0.000
M72.15 Knuckle pads-Pelvic/Thigh	0.002	0.998	0.000
M72.13 Knuckle pads-Forearm	0.002	0.998	0.000
M72.12 Knuckle pads-Upper arm	0.002	0.998	0.000
M72.11 Knuckle pads-Shldr region	0.002	0.998	0.000
M72.10 Knuckle pads (Multiple sites)	0.002	0.998	0.000
M72.14 Knuckle pads (Hand)	0.002	0.998	0.000
H54.7 Unspecified visual loss	0.002	0.998	0.000
G40.1 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures	0.002	0.998	0.000
I74.0 Embolism and thrombosis of abdominal aorta	0.002	0.998	0.000
H57.8 Other specified disorders of eye and adnexa	0.002	0.998	0.000
C97 Malignant neoplasms of independent (primary) multiple sites	0.002	0.998	0.000
H46-H48 Disorders of optic nerve and visual pathways	0.002	0.998	0.000
X63.9 Unspecified place	0.002	0.998	0.000
X63.8 Other specified place	0.002	0.998	0.000
X63.7 Farm	0.002	0.998	0.000
X63.6 Industrial and construction area	0.002	0.998	0.000
X63.5 Trade and service area	0.002	0.998	0.000
X63.4 Street and highway	0.002	0.998	0.000
X63.3 Sports and athletics area	0.002	0.998	0.000
X63.2 School, other institution and public administrative area	0.002	0.998	0.000
X63.1 Residential institution	0.002	0.998	0.000
R01 Cardiac murmurs and other cardiac sounds	0.002	0.998	0.000
M84.07 Malunion of fracture (Ankle and foot)	0.002	0.998	0.000
H55-H59 Other disorders of eye and adnexa	0.002	0.998	0.000
M21.26 Flexion deformity (Lower leg)	0.000	0.998	0.002
I11 Hypertensive heart disease	0.000	0.998	0.002
M72.28 Plantar fascial fibromatosis-Other	0.002	0.998	0.000
M72.26 Plantar fascial fibromatosis-Lower Leg	0.002	0.998	0.000
M72.25 Plantar fascial fibromatosis-Pelvic/Thigh	0.002	0.998	0.000
M72.24 Plantar fascial fibromatosis-Hand	0.002	0.998	0.000
M72.23 Plantar fascial fibromatosis-Forearm	0.002	0.998	0.000
M72.22 Plantar fascial fibromatosis-Upper arm	0.002	0.998	0.000
M72.21 Plantar fascial fibromatosis-Shldr region	0.002	0.998	0.000
M72.20 Plantar fascial fibromatosis-Mult sites	0.002	0.998	0.000
H04.3 Acute and unspecified inflammation of lachrymal passages	0.002	0.998	0.000
I74.2 Embolism and thrombosis of arteries of the upper extremities	0.002	0.998	0.000
H54.5 Low vision, one eye	0.002	0.998	0.000
H59.8 Other postprocedural disorders of eye and adnexa	0.002	0.998	0.000
I27.2 Other secondary pulmonary hypertension	0.000	0.998	0.002
H54.0 Blindness, both eyes	0.002	0.998	0.000
O82.0 Delivery by elective Caesarean section	0.000	0.998	0.002
H58 Other disorders of eye and adnexa in diseases classified elsewhere	0.002	0.998	0.000
E87.8 Other disorders of electrolyte and fluid balance, not elsewhere classified	0.002	0.998	0.000
K90.3 Pancreatic steatorrhoea	0.002	0.998	0.000
K90.2 Blind loop syndrome, not elsewhere classified	0.002	0.998	0.000
K90.1 Tropical sprue	0.002	0.998	0.000
H54 Blindness and low vision	0.002	0.998	0.000
H59 Postprocedural disorders of eye and adnexa, not elsewhere classified	0.002	0.998	0.000
S32.40 Fracture of acetabulum (closed)	0.002	0.998	0.000
R23.4 Changes in skin texture	0.000	0.998	0.002
H04 Disorders of lachrymal system	0.002	0.998	0.000
M72.29 Plantar fascial fibromatosis-Site unspec	0.001	0.998	0.000
N13.8 Other obstructive and reflux uropathy	0.000	0.998	0.002
M00.96 Pyogenic arthritis, unspecified (Lower leg)	0.000	0.998	0.002
C34.0 Main bronchus	0.000	0.998	0.002
O41.0 Oligohydramnios	0.000	0.998	0.002
X69.9 Unspecified place	0.002	0.998	0.000
H58.8 Visual disturbances in diseases classified elsewhere	0.002	0.998	0.000
T17.9 Foreign body in respiratory tract, part unspecified	0.002	0.998	0.000
H48 Disorders of optic [2nd] nerve and visual pathways in diseases classified elsewhere	0.002	0.998	0.000
N12 Tubulo-interstitial nephritis, not specified as acute or chronic	0.000	0.998	0.002
X69 Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances	0.002	0.998	0.000
H04.8 Other disorders of lachrymal system	0.002	0.998	0.000
H59.9 Postprocedural disorder of eye and adnexa, unspecified	0.002	0.998	0.000
O63.9 Long labour, unspecified	0.000	0.998	0.002
R01.2 Other cardiac sounds	0.001	0.998	0.000
X63.99 Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous system; Unspecified place ;During unspecified activity	0.001	0.998	0.000
N34.2 Other urethritis	0.002	0.998	0.000
X60-X84 Intentional self-harm	0.002	0.998	0.000
R23.0 Cyanosis	0.000	0.998	0.002
H46 Optic neuritis	0.002	0.998	0.000
C32.0 Glottis	0.000	0.998	0.002
T17 Foreign body in respiratory tract	0.002	0.998	0.000
G30 Alzheimer's disease	0.002	0.998	0.000
R23 Other skin changes	0.000	0.998	0.002
I74.8 Embolism and thrombosis of other arteries	0.001	0.998	0.000
X70 Intentional self-harm by hanging, strangulation and suffocation	0.001	0.998	0.000
X68 Intentional self-poisoning by and exposure to pesticides	0.001	0.998	0.000
G30.1 Alzheimer's disease with late onset	0.001	0.998	0.000
H04.0 Dacryoadenitis	0.001	0.998	0.000
H54.2 Low vision, both eyes	0.001	0.998	0.000
H58.9 Other specified disorders of eye and adnexa in diseases classified elsewhere	0.001	0.998	0.000
H58.1 Visual disturbances in diseases classified elsewhere	0.001	0.998	0.000
H58.0 Anomalies of pupillary function in diseases classified elsewhere	0.001	0.998	0.000
H54.3 Unqualified visual loss, both eyes	0.001	0.998	0.000
X84 Intentional self-harm by unspecified means	0.001	0.998	0.000
H04.4 Chronic inflammation of lachrymal passages	0.001	0.998	0.000
X67.9 Unspecified place	0.001	0.998	0.000
X69.0 Home	0.001	0.998	0.000
M72.27 Plantar fascial fibromatosis-Ankle/Foot	0.001	0.999	0.000
H04.6 Other changes in lachrymal passages	0.001	0.999	0.000
H48.8 Other disorders of optic nerve and visual pathways in diseases classified elsewhere	0.001	0.999	0.000
H48.1 Retrobulbar neuritis in diseases classified elsewhere	0.001	0.999	0.000
H48.0 Optic atrophy in diseases classified elsewhere	0.001	0.999	0.000
X68.9 Unspecified place	0.001	0.999	0.000
H57 Other disorders of eye and adnexa	0.001	0.999	0.000
X80 Intentional self-harm by jumping from a high place	0.001	0.999	0.000
X67 Intentional self-poisoning by and exposure to other gases and vapours	0.001	0.999	0.000
X60 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics	0.001	0.999	0.000
H54.1 Blindness, one eye, low vision, other eye	0.001	0.999	0.000
X60.1 Residential institution	0.001	0.999	0.000
X69.8 Other specified place	0.001	0.999	0.000
X69.7 Farm	0.001	0.999	0.000
X69.6 Industrial and construction area	0.001	0.999	0.000
X69.5 Trade and service area	0.001	0.999	0.000
X69.4 Street and highway	0.001	0.999	0.000
X69.3 Sports and athletics area	0.001	0.999	0.000
X69.2 School, other institution and public administrative area	0.001	0.999	0.000
X69.1 Residential institution	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations